Piramal Pharma Sees Surge in Open Interest Amid Complex Trading Environment
Piramal Pharma Ltd has seen a significant rise in open interest, indicating increased trading activity. The stock's performance shows it has outperformed its sector slightly, although it remains below several key moving averages. A decline in delivery volume suggests reduced investor participation, despite maintaining adequate liquidity for trades.
Piramal Pharma Ltd (PPLPHARMA) has experienced a notable increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 1,585 contracts, up from the previous 1,410 contracts, marking a change of 175 contracts or a 12.41% increase. The trading volume for the day reached 945 contracts, contributing to a futures value of Rs 1,776.36 lakhs and an options value of Rs 312,639,325, bringing the total value to Rs 1,842.25 lakhs. The underlying value of the stock is reported at Rs 205.In terms of performance, Piramal Pharma has outperformed its sector by 0.64%, reversing a two-day decline. The stock's current price is higher than its 5-day moving averages but remains below the 20-day, 50-day, 100-day, and 200-day moving averages. However, there has been a decline in investor participation, with delivery volume dropping by 58.29% compared to the 5-day average. Despite this, the stock maintains sufficient liquidity for trades sized at Rs 1.69 crore.
In summary, the increase in open interest for Piramal Pharma indicates a shift in market dynamics, while the stock's performance metrics reflect a complex trading environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
